{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:14:55Z","timestamp":1786994095398,"version":"build-2736575974"},"reference-count":38,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T00:00:00Z","timestamp":1718841600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Med"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.medj.2024.06.005","type":"journal-article","created":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T10:32:51Z","timestamp":1720607571000},"page":"1266-1274.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Phenotypic subgroup in serologically active clinically quiescent systemic lupus erythematosus: A cluster analysis based on CSTAR cohort"],"prefix":"10.1016","volume":"5","author":[{"given":"Yufang","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangzhong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinwang","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanyuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangzhu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinping","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengtao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9308-2858","authenticated-orcid":false,"given":"Jiuliang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medj.2024.06.005_bib1","first-page":"2239","article-title":"Serologically active clinically quiescent systemic lupus erythematosus--predictors of clinical flares","volume":"21","author":"Walz LeBlanc","year":"1994","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.medj.2024.06.005_bib2","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/0002-9343(79)90529-1","article-title":"Serologically active clinically quiescent systemic lupus erythematosus: A discordance between clinical and serologic features","volume":"66","author":"Gladman","year":"1979","journal-title":"Am. J. Med."},{"key":"10.1016\/j.medj.2024.06.005_bib3","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/acr.21568","article-title":"Outcomes in patients with systemic lupus erythematosus with and without a prolonged serologically active clinically quiescent period","volume":"64","author":"Aj","year":"2012","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.medj.2024.06.005_bib4","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.3899\/jrheum.100007","article-title":"Prolonged serologically active clinically quiescent systemic lupus erythematosus: frequency and outcome","volume":"37","author":"Steiman","year":"2010","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.medj.2024.06.005_bib5","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s13075-021-02641-5","article-title":"Treatments and outcomes in Chinese patients with serologically active clinically quiescent systemic lupus erythematosus: a retrospective observational study","volume":"23","author":"Huang","year":"2021","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.medj.2024.06.005_bib6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/ard-2023-224762","article-title":"EULAR recommendations for the management of systemic lupus erythematosus: 2023 update","volume":"83","author":"Fanouriakis","year":"2024","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.medj.2024.06.005_bib7","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1002\/art.22198","article-title":"The effect of moderate-dose corticosteroids in preventing severe flares in patients with serologically active, but clinically stable, systemic lupus erythematosus: findings of a prospective, randomized, double-blind, placebo-controlled trial","volume":"54","author":"Tseng","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.medj.2024.06.005_bib8","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/rheumatology\/keac225","article-title":"Low-dose glucocorticoids withdrawn in systemic lupus erythematosus: a desirable and attainable goal","volume":"62","author":"Ji","year":"2022","journal-title":"Rheumatology"},{"key":"10.1016\/j.medj.2024.06.005_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v061.i06","article-title":"NbClust: An R Package for Determining the Relevant Number of Clusters in a Data Set","volume":"61","author":"Charrad","year":"2014","journal-title":"J. Stat. Softw."},{"key":"10.1016\/j.medj.2024.06.005_bib10","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1136\/annrheumdis-2017-211206","article-title":"Epidemiology and burden of systemic lupus erythematosus in a Southern European population: data from the community-based lupus registry of Crete, Greece","volume":"76","author":"Gergianaki","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.medj.2024.06.005_bib11","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.berh.2018.09.004","article-title":"Update on the epidemiology, risk factors, and disease outcomes of systemic lupus erythematosus","volume":"32","author":"Gergianaki","year":"2018","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"10.1016\/j.medj.2024.06.005_bib12","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1016\/S2665-9913(19)30105-5","article-title":"Factors associated with damage accrual in patients with systemic lupus erythematosus with no clinical or serological disease activity: a multicentre cohort study","volume":"2","author":"Apostolopoulos","year":"2020","journal-title":"Lancet. Rheumatol."},{"key":"10.1016\/j.medj.2024.06.005_bib13","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1136\/annrheumdis-2013-205171","article-title":"Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort","volume":"74","author":"Bruce","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.medj.2024.06.005_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2016.02.003","article-title":"Clinical and pathologic considerations of the qualitative and quantitative aspects of lupus nephritogenic autoantibodies: A comprehensive review","volume":"69","author":"Gatto","year":"2016","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.medj.2024.06.005_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.526","article-title":"Glucocorticoid-induced osteonecrosis in systemic lupus erythematosus patients","volume":"11","author":"Kaneko","year":"2021","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.medj.2024.06.005_bib16","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1093\/rheumatology\/keu148","article-title":"Glucocorticoids and irreversible damage in patients with systemic lupus erythematosus","volume":"53","author":"Ruiz-Arruza","year":"2014","journal-title":"Rheumatology"},{"key":"10.1016\/j.medj.2024.06.005_bib17","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/0961203307086643","article-title":"Hydroxychloroquine: the cornerstone of lupus therapy","volume":"17","author":"Ruiz-Irastorza","year":"2008","journal-title":"Lupus"},{"key":"10.1016\/j.medj.2024.06.005_bib18","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/ard.2007.070367","article-title":"EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics","volume":"67","author":"Bertsias","year":"2008","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.medj.2024.06.005_bib19","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/08916930400022715","article-title":"Anti-Sm and anti-RNP antibodies","volume":"38","author":"Migliorini","year":"2005","journal-title":"Autoimmunity"},{"key":"10.1016\/j.medj.2024.06.005_bib20","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s10875-012-9825-6","article-title":"Simultaneous positivity for anti-DNA, anti-nucleosome and anti-histone antibodies is a marker for more severe lupus nephritis","volume":"33","author":"Sui","year":"2013","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.medj.2024.06.005_bib21","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/art.22356","article-title":"Association of antinucleosome antibodies with disease flare in serologically active clinically quiescent patients with systemic lupus erythematosus","volume":"55","author":"Ng","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.medj.2024.06.005_bib22","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.clim.2016.08.001","article-title":"Lupus nephritis biomarkers","volume":"185","author":"Soliman","year":"2017","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.medj.2024.06.005_bib23","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.2215\/CJN.04830421","article-title":"When and How Is It Possible to Stop Therapy in Patients with Lupus Nephritis: A Narrative Review","volume":"16","author":"Moroni","year":"2021","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.medj.2024.06.005_bib24","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1136\/annrheumdis-2022-222435","article-title":"Weaning of maintenance immunosuppressive therapy in lupus nephritis (WIN-Lupus): results of a multicentre randomised controlled trial","volume":"81","author":"Jourde-Chiche","year":"2022","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.medj.2024.06.005_bib25","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2021-000603","article-title":"Risk factors of flare in patients with systemic lupus erythematosus after glucocorticoids withdrawal. A systematic review and meta-analysis","volume":"9","author":"Ji","year":"2022","journal-title":"Lupus Sci. Med."},{"key":"10.1016\/j.medj.2024.06.005_bib26","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3899\/jrheum.160214","article-title":"Cumulative Burden of Glucocorticoid-related Adverse Events in Patients with Systemic Lupus Erythematosus: Findings from a 12-year Longitudinal Study","volume":"45","author":"Chen","year":"2018","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.medj.2024.06.005_bib27","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002701","article-title":"Glucocorticoid tapering and associated outcome in patients with newly diagnosed systemic lupus erythematosus: the real-world GULP prospective observational study","volume":"8","author":"Floris","year":"2022","journal-title":"RMD Open"},{"key":"10.1016\/j.medj.2024.06.005_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103446","article-title":"Is it safe to withdraw low-dose glucocorticoids in SLE patients in remission?","volume":"23","author":"Mathian","year":"2024","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.medj.2024.06.005_bib29","article-title":"Transparent reporting of multivariable prediction models developed or validated using clustered data: TRIPOD-Cluster checklist","volume":"380","author":"Debray","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.medj.2024.06.005_bib30","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2478\/rir-2021-0001","article-title":"Chinese SLE Treatment and Research Group (CSTAR) Registry 2009-2019: Major Clinical Characteristics of Chinese Patients with Systemic Lupus Erythematosus","volume":"2","author":"Li","year":"2021","journal-title":"Rheumatol. Immunol. Res."},{"key":"10.1016\/j.medj.2024.06.005_bib31","doi-asserted-by":"crossref","first-page":"184","DOI":"10.2478\/rir-2022-0033","article-title":"RheumCloud App: A Novel Mobile Application for the Management of Rheumatic Diseases Patients in China","volume":"3","author":"Huang","year":"2022","journal-title":"Rheumatol. Immunol. Res."},{"key":"10.1016\/j.medj.2024.06.005_bib32","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.medj.2024.06.005_bib33","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1136\/annrheumdis-2015-207726","article-title":"Definition and initial validation of a Lupus Low Disease Activity State (LLDAS)","volume":"75","author":"Franklyn","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.medj.2024.06.005_bib34","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1056\/NEJMoa051135","article-title":"Combined oral contraceptives in women with systemic lupus erythematosus","volume":"353","author":"Petri","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.medj.2024.06.005_bib35","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/annrheumdis-2019-216303","article-title":"Withdrawal of low-dose prednisone in SLE patients with a clinically quiescent disease for more than 1 year: a randomised clinical trial","volume":"79","author":"Mathian","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.medj.2024.06.005_bib36","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.medj.2024.06.005_bib37","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/acr.21664","article-title":"American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis","volume":"64","author":"Hahn","year":"2012","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.medj.2024.06.005_bib38","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF01896809","article-title":"Metric and Euclidean properties of dissimilarity coefficients","volume":"3","author":"Gower","year":"1986","journal-title":"J. Classif."}],"container-title":["Med"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666634024002514?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666634024002514?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T11:50:25Z","timestamp":1728647425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666634024002514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S2666634024002514"],"URL":"https:\/\/doi.org\/10.1016\/j.medj.2024.06.005","relation":{},"ISSN":["2666-6340"],"issn-type":[{"value":"2666-6340","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phenotypic subgroup in serologically active clinically quiescent systemic lupus erythematosus: A cluster analysis based on CSTAR cohort","name":"articletitle","label":"Article Title"},{"value":"Med","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medj.2024.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}